The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

St. Jude Medical Inc

NYSE: STJ
Last

(U.S.) $68.23

Today's change0.00 0.00%
Updated April 20 4:01 PM EDT. Delayed by at least 15 minutes.
 

St. Jude Medical Inc

NYSE: STJ
Last

(U.S.) $68.23

Today's change0.00 0.00%
Updated April 20 4:01 PM EDT. Delayed by at least 15 minutes.

St. Jude Medical Inc closed at (U.S.)$68.23.

Over the last five days, shares have gained 0.86% and 4.92% year to date. Shares have underperformed the S&P 500 by 3.45% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $68.23
  • High--
  • Low--
  • Bid / Ask(U.S.) $54.83 / (U.S.) $2.00K
  • YTD % change+4.92%
  • Volume0
  • Average volume (10-day)1,473,667
  • Average volume (1-month)1,469,368
  • Average volume (3-month)1,994,633
  • 52-week range(U.S.) $54.80 to (U.S.) $71.90
  • Beta1.32
  • Trailing P/E19.73×
  • P/E 1 year forward17.28×
  • Forward PEG2.10×
  • Indicated annual dividend(U.S.) $1.16
  • Dividend yield1.70%
  • Trailing EPS(U.S.) $3.46
Updated April 20 4:01 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+16.99%

Based on its net profit margin of 16.99%, St. Jude Medical Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.00%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2014Q3/2014Q2/2014Q1/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJan 03, 201501/03/2015Sep 27, 201409/27/2014Jun 28, 201406/28/2014Mar 29, 201403/29/2014
Revenue1,4391,3721,4481,363
Total other revenue--------
Total revenue1,4391,3721,4481,363
Gross profit1,0199841,041981
Total cost of revenue420388407382
Total operating expense1,1591,1021,1591,051
Selling / general / administrative378461492463
Research & development175169178170
Depreciation / amortization89------
Interest expense (income), net operating--------
Unusual expense (income)97848236
Other operating expenses, total--------
Operating income280270289312
Interest income (expense), net non-operating-22-21-21-21
Gain (loss) on sale of assets--------
Other--------
Income before tax258250268292
Income after tax238232246239
Income tax, total20182253
Net income245238270249
Total adjustments to net income--------
Net income before extra. items245238270249
Minority interest762410
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items245238270249
Inc. avail. to common incl. extra. items245238270249
Diluted net income245238270249
Dilution adjustment00--0
Diluted weighted average shares291290289289
Diluted EPS excluding extraordinary itemsvalue per share0.840.820.930.86
Dividends per sharevalue per share0.270.270.270.27
Diluted normalized EPSvalue per share1.151.091.200.96